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Several adverse health effects (including cancer and noncancer effects) may be the result of an
imbalance between exogenous and endogenous invading substances and defense
mechanisms. In these cases the probability of an adverse effect depends on how much the
exposure to a substance increases or decreases the number of defenders or their efficiency as
well as increasing or decreasing the number of invaders. Rather than using a dose scale such
as parts per million or milligram/kilogram/day in these cases, dose-response models can
directly incorporate the impact of defense mechanisms by using a dose scale that corresponds
to the number of invaders that break through the defenders and become free to do their
damage. The number of breakthroughs at a specific age, the cumulative number of
breakthroughs by a specific age, or the cumulative number of breakthroughs in a window of
time would usually be the appropriate age-dependent dose. Although a lifetime average daily
dose level can be used as a surrogate for an age-dependent dose in simplistic dose-response
models, the age-dependent dose itself can be used in more biologically based models that
include time, reflect the key role of feedback mechanisms, and treat the human body as an age-
dependent dynamic system responding to internal and external stimuli and not as a system at
equilibrium. Some illustrative biologic examples of defense mechanisms and invader-defender
interactions are presented. Several numerical examples are given in which the dose incorporates
the age-dependent effects of a substance on the number of invaders, the number of defenders,
and/or the defenders' efficiencies. Environ Health Perspect 106(Suppl 1):341-348 (1998).
http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-1/341-348sielken/abstract.html
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Introduction
Health is a balance between harmful and
helpful forces. This balance can be mod-
eled by considering the relative proportions
of invaders and defenders and an individ-
ual defender's efficiency in defeating a
single invader.
Several adverse health effects (including
both cancer and noncancer effects) may be
the result of an imbalance between exoge-
nous and endogenous invading substances
and defense mechanisms. Opposing forces
are involved in most normal physiologic
processes as well as in abnormal processes
such as cancer, infectious diseases, immune
system disorders, neurotoxicity, organ
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toxicity, adverse reproductive effects,
teratogenesis, and developmental problems.
Most chemicals are considered to be
invaders although their metabolism by
defense enzyme systems is usually to less
toxic metabolites. The cytochrome P450
system is one such system that is induced at
low-level exposures-in some cases this is
the earliest measure of exposure. This
induction is also related to the increased
synthesis of ascorbic and glucaric acids in
the liver, and both ofthese acids can inhibit
certain steps of the carcinogenic process.
Another important defense mechanism in
this process is cell-cycle arrest or apoptosis
depending on the degree of activation of
the p53 gene. There are many examples of
enhanced defenses relating to the immune
system. The responses of the whole organ-
ism can be modified by lifestyle changes,
regular aerobic exercise, diet content,
caloric restriction, supplementation with
antioxidants (including green tea and other
plant sources of flavonoids), degree of
stress, etc.
Some ofthese effects are almost qualita-
tive; e.g., inhibition of the carcinogenic
response by caloric restriction. There also
are some examples in which exposure to a
chemical leads to an adverse health effect,
but ifthat exposure is preceded by exposure
to some other specific chemical, there is no
adverse health effect. In such cases the other
specific chemical is enhancing some defense
mechanisms. It long has been known that
many defense mechanisms tend to become
less effective with age and that when
enhanced they may increase average life
span but not necessarily maximum life span.
Defense mechanisms should be an
important component of risk assessment
and dose-response modeling. Inclusion of
defense mechanisms and the whole
invaders/defenders concept provides an
opportunity to make dose-response mod-
els more biologically based and to incorpo-
rate more of the available scientific data.
Furthermore, their inclusion can have a
significant impact on the shape of dose-
response relationships. When defense
mechanisms are stimulated at low exposure
levels, protective or hormetic responses are
possible. Historically, the saturation of
enzyme systems has been considered the
major source ofpotential nonlinearity and
the role ofkey defense mechanisms induced
by low levels ofexposure has been ignored.
This paper reviews the invaders/defenders
concept developed in earlier papers (1-4),
illustrates how the concept can be incorpo-
rated into dose-response modeling, pro-
vides numeric examples, and indicates
potential generalizations and avenues of
further research. The intent ofthis paper is
to make the invaders/defenders concept a
practical tool for more biologically based
dose-response modeling and for generating
researchstrategies.
Specific Biologic Examples
In risk assessment some inherent mathe-
matical assumptions have had a major
influence on the models used. For instance,
a body is considered to continue in its cur-
rent state of rest or uniform motion unless
it is compelled to change that state by
forces impressed on it. Thus, it is assumed
that all bodies or animals in a model are in
a state ofequilibrium and there is only one
force (i.e., carcinogen exposure) acting on
them. This is not biologic reality. Several
factors (including exposure and defense
mechanisms) may change the characteristics
of the biologic system. These multiple
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changes occur in many ways, and what is
observed is only the net result ofcomplex
interactions that change over time. It may
only be possible to model such complex
processes approximately, but at least the
additional factors known to exist should be
considered. It must also be acknowledged
that all bodies are not equal, for in biology
major species and strain differences in
response may reflect major differences in
defense mechanisms.
Two different specific biologic examples
are given to demonstrate how the character-
istics ofbiologic systems maychange.
Example 1
In initiation-promotion protocols for the
production of tumors (particularly skin
and liver), an initiating dose of a com-
pound such as diethylnitrosamine is
given, followed several days later by the
longer-term administration of a pro-
moter. This protocol gives a tumor yield
when administration of either the initia-
tor or promoter separately would not.
Phenobarbital is a drug used in many
such initiation-promotion protocols.
When phenobarbital alone is adminis-
tered to rats, there is an initial burst ofDNA
synthesis ofa few days, but within 1 week
the animals become refractory to the toxi-
cant with respect to DNA synthesis. Ifan
initiator is administered after phenobarbital
(or promoter), the rats are also refractory to
the initiator, which implies that there has
been an increase in defenses. There is a time
sequence to this because when the initiator
is given before phenobarbital and phenobar-
bital is given either continuously or only
intermittently, the latter sequence is more
effective in inducing DNA synthesis. This
suggests that the refractory state is readily
reversible (5). Among the biochemical
events that occur with phenobarbital expo-
sure are induction ofthe cytochrome P450
enzymes, a reduction in livervitamin E con-
centration, and an increased synthesis of
ascorbic and glucaric acids. All these com-
pounds are antioxidants and can inhibit
chemically induced DNA synthesis. Of
course, enzyme induction is also a form of
self-induced defense. Thus, exposure has
changed the nature ofthe defenses.
Example 2
The carcinogenic response may be
profoundly altered by the quantity and
composition of diet. U.S. National
Toxicology Program researchers have been
concerned about the increasing incidence
of liver tumors in their rodent bioassays
and have considered increasing the amount
ofvitamin E in the diets used. In essence
this would modulate a carcinogenic
response by increasing the defense mecha-
nisms. However, it may not be as effective
as other interventions. In a recent study (
Klaunig, unpublished data) that examined
the relationship between dieldrin-induced
mouse liver tumors in the presence or
absence ofvitamin E supplementation, it
was found that although at 10 months vit-
amin E appeared to be have reduced the
tumor incidence in both control and dield-
rin-treated animals, by 18 months it had
actually increased the proportion ofcontrol
animals with liver tumors and had not
protected the dieldrin-exposed animals.
Vitamin E decreased the incidence of
apoptotic nuclei by about 75% in hepatic
adenomas, suggesting that an apparent
defense mechanism may have paradoxic
effects in tumor tissue. Furthermore, the
liver glutathione concentration, which falls
by a factor of4 or 5 in older animals, was
high in dieldrin-induced liver tumors.
Thus, the ability ofanimals to utilize their
defense mechanisms appears to be age
dependent and tumors may acquire more
efficient defenses than theirhosts.
Examples such as these show that the
carcinogenic process is subject to sub-
stantial forces in both directions and also
that the impact of these forces may be
time dependent.
Invaders and Defenders
The invaders/defenders concept is quite
intuitive. Invaders (e.g., molecules of a
toxic chemical) enter the body or a specific
tissue or cell and try to attack a system, a
tissue, or a cell component. Each defender
(e.g., an individual molecule or larger com-
ponent of the defense mechanisms ofthe
cell, tissue, or body) has a probability of
preventing an individual invader from suc-
cessfully attacking its target. The defeat of
an invader is a broad idea encompassing
the interaction of molecules, cells like
phagocytes, the storing of damage in a
harmless form such as in the case ofcell-
cycle arrest, or the elimination ofdamage
(e.g., apoptosis).
For the numerical examples in this
paper, the rules ofcombat between invader
and defender are as follows; however, these
rules could be modified ifappropriate. An
invader must successfully escape defeat at
the hands ofeach available defender. When
an invader confronts a defender, the
defender has a specified probability of
defeating (neutralizing or destroying) the
invader-for simplicity this probability is
called the defender's efficiency and is
denoted mathematically as DE. Thus, if
the initial number ofdefenders is ND, the
probability that the first invader is not
defeated by any of the initial ND is
(1-DE)ND. If the invader is not defeated
by any available defender, the invader is
said to have broken through the defense
system and is free to damage its target. If
an invader is defeated by a defender, that
defender is used up and is not available to
confront the next invader. Thus, if the
number ofinvaders, NI, is large and several
of the early invaders are defeated, later
invaders face fewer defenders and have a
greater probability ofbreakthroughs. The
total number ofbreakthroughs, NB, is a
random variable that depends on the NI,
the ND, and the DE.
Therefore, for a given number of
invaders the number of breakthroughs
increases as the number of defenders
decreases and vice versa (Figure 1). Similarly,
the numberofbreakthroughs increases as the
individual defender's efficiency decreases
andvice versa (Figure 2).
Monte Carlo simulation routines can
be used to determine large numbers ofran-
dom realizations of the age-dependent
number ofbreakthroughs as well as to esti-
mate the age-dependent expected number
ofbreakthroughs (i.e., the mean number of
breakthroughs at a particular age). The age-
dependent expected number of break-
throughs is an age-dependent single number
summarization ofthe stochastic interaction
between invaders and defenders and the
resultant random number ofbreakthroughs.
In the discussions that follow, the term
number ofbreakthroughs is interpreted as
either alarge number ofrandom realizations
ofthe age-dependent series ofnumbers of
breakthroughs or the age-dependent
expected number ofbreakthroughs. In the
numerical examples the number ofbreak-
throughs is the age-dependent expected
number ofbreakthroughs.
Incorporating the Concept of
Invaders and Defenders into
Dose-Response Models
AMoreBiologically
RelevantDoseScale
Most dose-response models for adverse
health effects are either strictly curve-fitting
models or rough mathematical representa-
tions ofa general mechanistic hypothesis
(e.g., a multistage model for carcinogenesis).
In either case, the dose in these models can
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Figure 1. An example of the impact of the number of defenders on the expected number of breakthroughs. Each
defender has a 50% chance of defeating an invader(number of invaders =25).
EJ80% chance-
30% chance
20% chance
<0_
20
- 200 15chan30 35 Uce5
defender as a 50%chance ofdefeatin an invadr (numbe of invadrsc=a25)
x/
a)
-C_I'~* 0%cac
'__8%canc
25-/U) 7%cac
1 5 10 15 20 25 30 35 40 45 50
Defenders, no
Figure 2. An example of the impact of an individual defender's efficiency (chance) on the expected number of
breakthroughs. Each defender has a chance ofdefeating an invader(number of invaders =25).
invaders and defenders are involved, a
relevant biologically effective dose is
the expected number of breakthroughs
corresponding to the exposure.
A practical means ofincorporating the
role of invaders and defenders into the
dose-response modeling for an adverse
health effect is by defining the dose in the
dose-response model to be the expected
number of breakthroughs corresponding
to the exposure. This dose scale reflects
the exposure's impact on the number of
invaders, the number ofdefenders, and the
individual defender's efficiency.
DoseEqual totheNumber
ofBreakuhroughs
Even the simplest dose-response models like
the linear multistage model and the one-hit
model for cancer can be made to at least
modestly reflect the role of invaders and
defenders if the dose in these models is
defined to be the number ofbreakthroughs.
Specifically, these two dose-response models
would become
Probability ofadverse health effect (P) at
administered dose D=
1-exp 1-[cto+al x(NBat D)]}
or, equivalently,
P(D) = 1 -exp {-[a0+a, x NB(D)]}.
Figures 3 and 4 give a simple illustration of
this type ofdose relationship; i.e., how the
probability PD) ofan adverse health effect
would change as the administered dose D
changes. In Figure 3A the number of
invaders increases linearly with D, whereas
there is a saturable increase in the number
ofdefenders with D. Figure 3B shows how
the resulting number of breakthroughs
changes as D changes. Figure 4 shows a
plot of the resulting dose-response model
(with ao =0 andet= 1)
be any biologically relevant characteristic of
an exposure. The most common and most
simple dose scale is the administered or
applied dose (e.g., milligram/kilogram/day
or parts per million). However, this dose
scale reflects the least amount ofinforma-
tion about the exposure. Alternative dose
scales offer an important opportunity to
incorporate more biologic information into
dose-response modeling and result in a
more biologically based dose-response
model. A better alternative dose scale than
the administered dose often is the delivered
dose, which corresponds to the amount of
the chemical or its metabolite that actually
reaches the target tissue. The objective of
physiologically based pharmacokinetic
models is to determine the delivered dose.
However, an even better alternative dose
scale is the biologically effective dose, which
reflects not only the amount delivered to the
target tissue but also the net amount of
some relevant activity related to the health
effect that occurs after delivery. When
P(D) = 1 -exp {-NB(D)}.
The shape ofthis linear multistage or one-
hit model is linear in the dose NB(D).
However, the shape of the model versus
the administered dose D clearly is nonlin-
ear and hormetic because ofthe decreasing
probability of an adverse health effect for
Dbetween D=0 and D= 10.
The shape and low-dose behavior of a
dose-response relationship with the dose
defined as the number ofbreakthroughs is
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Figure 3. An example of a hormetic effect on the number of breakthroughs (B) associated with a linear increase in
the number of invaders with dose (A) accompanied by a saturable increase in the number of defenders. Number of
invaders=5+dose; Number ofdefenders =10+20[1 -exp(-0.75xdose)l; individual defender's efficiency=50%.
determined by the number ofinvaders (a
background number ofinvaders plus possi-
bly an administered-dose-dependent number
ofadditional invaders), number ofdefenders,
and the efficiency ofeach defender.
In general, the number ofdefenders is a
background number ofdefenders plus pos-
sibly an administered-dose-dependent
number ofadditional defenders.
AgeDependencies
Life is a continuous process in which
conditions change with time and/or age.
Most human and animal physiologic
processes change significantlywith age, typ-
ically with reductions in function or degree
of responses. Such changes can make the
number ofinvaders, number ofdefenders,
and/or the defender's efficiency change
with age. Exposure levels and the adminis-
tered dose can change over time. Ifexpo-
sures levels relate to a specific event like a
fire or an accident, the administered dose is
time dependent. Also, occupational expo-
sure levels change as jobs and techniques
change and may not occur at all for some
ages. Changes in the administered dose can
also change the number ofinvaders, num-
ber ofdefenders, and/or the defender's effi-
ciency. Thus, the number ofbreakthroughs
maychangewith time and/or age.
IncorporatingAge Dependencies
A Dose-response models like the multistage
1.0 0.983 0.9997 0.9999 1.0 and one-hit models do not explicitly incor-
porate age-dependent changes in the dose.
However, such dose-response models can
.j: 0.568 / be generalized to incorporate a dose like
m2 /the number of breakthroughs, which CID
changes over time or with age.
XC | 0.031 0.017 0.031 ° / Computer software exists that imple-
0 i 1__
ments quantitative dose-response models
0 5 10 15 20 25 30 35 40 with time-dependent or age-dependent
Administered dose, D dose levels (e.g., GEN.T, anIBM-compati-
ble personal computer program available
B from Sielken, Inc., Bryan, TX). Software is
0.125- 0.122 available from the authors into which the
components necessary to derive an age-
is / dependent number ofbreakthroughs can be
explicitly entered and the age-dependent
number of breakthroughs determined.
Currently these age-dependent components
0.031 0. are the background number ofinvaders,
background number of defenders, defender
efficiency, and administered dose, as well as
o , the functional relationship between an
0 5 10 15 administered dose level and the additional
Administered dose, D numbers ofinvaders and defenders.
The dose-response models incorporating
Figure 4. An example of a dose-response model where the impact of the administered dose is on the number of the invaders/defenders concept can be used
invaders, defenders, and breakthroughs as shown in Figure 3. (Bis an enlargement ofthe lowerdose portion ofA.) for hypothesis generation and exploratory
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evaluation ofhypothetical scenarios. In addi-
tion, software is available from the authors
that can link dose-response models with
maximum likelihood estimation techniques
to fit observed data to dose-response models
incorporating invaders and defenders and
their time and/or age dependencies.
Sample Dose-ResponseModels
The invaders/defenders concept can be
used with any existing dose-response
model. This is done by defining the dose in
the models to be the number of break-
throughs. Obviously models will be more
biologically realistic if the dose-response
model allows an age-dependent dose scale
in which the full age-dependent nature
of the number of breakthroughs can be
incorporated rather than a single-number
summaryofthe number ofbreakthroughs.
Two additional examples of general
dose-response models including the
invaders/defenders concept and an age-
dependent number of breakthroughs are
described in this section.
As is frequently done in human epi-
demiologic modeling, the age-dependent
probability ofan adverse health effect can be
modeled as a proportional hazards model in
which the age-dependent multiplier ofthe
age-dependent background hazard rate is a
function ofthe age-specific dose-here the
age-specific dose would be the age-specific
number ofbreakthroughs. In such dose-
response models, the probability (P[TE D(t),
t=0,..., 71, which for simplicity is denoted
by P[T; D(t)]), ofa specified adverse health
effect by age Twhen the age-dependent
administered dose is D(t) at age tis
P[T; D(t)] = 1 -exp{ oJTXo(t)
xPHM[t,D(t)]dd
where the proportional hazards multiplier
(PHM) is
PHM[k,D(t)] =exp{ao+a1 x [NB(t)]
+ 2x X[NB(t)]2+...I
in which the age-dependent and adminis-
tered-dose-dependent number of break-
throughs at age t, say NB[g, D(t)], has been
denoted by NB(t).
NB(t), the number ofbreakthroughs at
age t, is a function of the history of the
number ofinvaders, number ofdefenders,
and individual defender's efficiency up to
age t. NIand NDat age tcould be the sum
of a background number (NIo and NDo,
respectively) and an additional adminis-
tered-dose-dependent number (ANIand
AND, respectively); for example,
NJ[t, D(t)] =NIO(t) +ANI[D(t)]
ND[t, D(t)] =ND0(t) +AND[D(t)].
Alternatively, the age-dependent
probability of an adverse health effect can
be modeled with the hazard rate for the
adverse health effect being the sum of an
age-dependent background hazard rate and
an administered-dose-dependent hazard
rate. The administered-dose-dependent
hazard rate would depend on the adminis-
tered dose through the impact of the
administered dose on the number ofbreak-
throughs. In such dose-response models,
the probability (P[T; D(t)]) of a specified
adverse health effect by age Twhen the
age-dependent administered dose is D(t)
at age t is
P[T; D(t)] = 1-exp {oJTXo(t)
+XAdd [t,Dt)]dtl
where the administered-dose-dependent
hazard rate is
xAddrP, D(t)] =ao+al X[NB(t)] +a2
x[NB(t)]2 +
Model Components
andTheir Combinadon
The output ofthe dose-response model is
the probability ofa specified adverse health
effect for a specified administered dose.
This output will usually be expressed as an
added risk, namely,
added risk at age T=P[T; D(?f]
-P [T;O]0,
which is the increase in the probability ofa
specified adverse health effect for an
administered dose history of D(T) com-
pared to the same probability for dose zero.
The ultimate input to the dose-response
model is the number ofbreakthroughs. The
model components and their combination
to determine the added risk of a specified
adverse health effect are illustrated in Figure
5. The inputs determining the number of
breakthroughs are the age-dependent back-
ground number ofinvaders, age-dependent
background number of defenders, age-
dependent individual defender's efficiency,
age-dependent relationship between the
administered dose and additional number
of invaders, age-dependent relationship
between administered dose and additional
number ofdefenders, and age-dependent
administered dose.
The impact of the age-dependent
administered dose is to determine the age-
dependent additional number of invaders
and defenders.
The age-dependent additional number
of invaders and defenders combine with
their respective background numbers to
determine the age-dependent total number
of invaders and the age-dependent total
number ofdefenders.
The age-dependent total number
of invaders and defenders and the age-
dependent individual defender's efficiency
combine to determine the age-dependent
number ofbreakthroughs.
Finally, the age-dependent number of
breakthroughs determines the age-dependent
added riskofaspecified adversehealth effect.
Numerical Examples
For the invaders/defenders concept to
become a practical tool for dose-response
estimation and generation ofresearch strate-
gies, tools must exist that allowa riskassessor
or researcher to determine the quantitative
values of the numbers of breakthroughs
and added risks associated with different
specific numerical values for the compo-
nents ofthe invaders/defenders paradigm.
Figures 6 through 11 are specific numerical
examples ofapplying the general method-
ology illustrated in Figure 5 for specifying
the components of the invaders/defenders
paradigm and combining them to deter-
mine the added risk of a specified adverse
health effect.
Although the primary importance of
Figures 6 through 11 is to prove that the
invaders/defenders concept is a practical,
implemented, and available approach to
dose-response estimation and generation
of research strategies, the examples in the
figures are themselves somewhat interest-
ing. They illustrate what happens in several
situations. For example,
* when the number of defenders
decreases with age (Figure 6);
* when the number of defenders is
affected by feedback (Figure 7);
* when the administered dose has differ-
ent age dependencies (Figure 8);
* when the individual defender's efficiency
decreases with age (Figure 9);
* when the administered dose impacts
the numbers of both the invaders and
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Figure 5. Invader/defender components and their combination into a dose-response
model-based prediction ofthe added riskof a specified adverse health effect.
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Figure 6. Example 1: number of defenders decreasing with age.
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Figure 7. Example 1 (modified): numberofdefenders affected byfeedback.
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Figure 8. Example 1 (continued): impact ofage-dependent administered dose.
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Figure9. Example 2: individual defender's efficiency decreasing with age.
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Figure 10. Example 3: an age-dependent administered dose affecting the
numberof invaders and defenders.
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defenders and the administered dose is
age dependent (Figure 10); and
* when the administered dose affects the
numbers of both the invaders and
defenders and the magnitude ofan age-
independent administered dose changes
(Figure 11).
Generalizations
There are several generalizations of the
implementation ofthe invaders/defenders
concept described above. One generalization
would be for D(t) in the dose-response
models incorporating invaders and defenders
and their age dependencies to be expanded
to include any one ofthe following alterna-
tives: D(t), administered dose at age g D(t),
cumulative administered dose by age t D(t),
cumulative administered dose in a window
ofages (e.g., from t-20 to t); etc.
A second generalization would be for
NB(t) in the dose-response models incor-
porating invaders and defenders and their
age dependencies to be expanded to
include any one ofthe following alterna-
tives: NB(t), number ofbreakthroughs at
age t; NB(t), cumulative number ofbreak-
throughs by age t; NB(t), cumulative num-
ber ofbreakthroughs in a window ofages
(e.g., from t-20 to t); etc.
A third possible generalization would be
for the individual defender's efficiency to be
administered-dose dependent ifthe admin-
istered dose facilitates or hinders some
ancillary attribute relevant to the defender's
successful defeat ofan invader. For exam-
ple, the defender might work in conjunc-
tion with an enzyme and the administered
dose might affect the level ofthat enzyme.
Discussion
Incorporation ofdefense mechanisms and
the invaders/defenders concept is an impor-
tant new approach to developing more bio-
logically based dose-response models. The
invaders/defenders concept provides an
opportunity to incorporate time and age
dependencies, thebody as adynamic system,
and feedbackmechanisms into the model.
Like the innovative Moolgavkar-
Venzon-Knudsen models reflecting cell pro-
liferation in cancer dose-response modeling,
the incorporation ofthe invaders/defenders
concept allows the body to be more realisti-
cally treated as an age-dependent dynamic
system responding to external and internal
stimuli rather than asystem at equilibrium.
Although feedback mechanisms were
not specifically introduced into the above
examples, the invaders/defenders concept
can easily incorporate feedback mechanisms.
For example, the number of defenders,
ND(T), at age T could be treated as
dependent on the history (between t= 0
and t= T) ofthe number of invaders and
the history ofthe number ofdefenders. For
instance, ND( 7) could be proportional to
the cumulative number ofbreakthroughs
0JTNB(t) dt
or the largest number ofbreakthroughs in
the past
max [NB(t)].
O<t. T
Conclusions
Species and strain differences in the fre-
quencies ofadverse health effects could be
explained by species and strain differences
in the number ofinvaders, the number of
defenders, the individual defender's effi-
ciency, their age dependencies, and their
administered-dose dependencies.
The concept ofinvaders and defenders is
presented to stimulate interest in the multi-
factorial nature of the dose and dose-
response modeling ofadverse health effects
and to highlight the fact that defense mech-
anisms can play a major role in determina-
tion of the frequency of adverse health
effects. It can bepredicted, for instance, that
an increase in tumor incidence may occur
without additional exposures to carcinogens
ifan organism's defenses are depleted. This
side ofthe balance is not normally consid-
ered in the modeling ofthe carcinogenic
process. We were surprised by the number
offactors that mayproduce hormetic effects
in simulations. This suggests that hormesis
may be more widespread than generally rec-
ognized but that it may be confined to a
range ofdoses that perhaps fall below those
commonly employed in chronic bioassays,
particularly ifonly the maximum tolerated
dose and halfthis dose are used.
In the past it has been assumed (with
less than critical reasoning) that for some
adverse health effects like cancer, low-dose
linearity would be a general phenomenon.
The invaders/defenders model indicates
that even ifthe formation ofDNA adducts
is linear, there are many other factors that
may lead to low-dose nonlinearity or even
hormetic responses.
The concept ofinvaders and defenders
has ahigh degree ofpractical importance for
the evolution ofattitudes toward the reduc-
tion of the incidence of adverse health
effects. It demonstrates that attention to
factors that increase defenses may be as
important as the search for environmental
toxic chemicals. Specifically, defense mecha-
nisms are especially important because they
may modify the effects ofmultiple toxic
chemicals. More attention to the defense
systems that affect the adverse health effects
ofmultiple toxic chemicals may be more
important than focusing on the dose level of
a single chemical. The invaders/defenders
concept also leads to the realization that
adverse health effects may not only be the
result ofexogenous exposures-ifthere is a
steady stream ofendogenous invaders from
normal metabolic processes, depletion of
defenses will also result in disease. It is not
generally known how often this occurs
because nonspecific insults such as stress can
also affect thebody's defense system.
Consideration ofinvaders and defenders
in dose-response modeling is not merely an
academic exercise. We now have the dose-
response modeling tools to explore the qual-
itative and quantitative impact ofa variety
ofcombinations ofthe components ofthe
invaders/defenders phenomenon that may
lead to a range ofdose-response shapes.
These tools can be an important part of
more biologically based dose-response esti-
mation as well as being usefil in generating
research strategies. We hope that this paper
will stimulate such pursuits.
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